{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:07:05Z","timestamp":1789736825227,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007697","name":"Northern Advancement Center for Science and Technology","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100007697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02925"],"award-info":[{"award-number":["22H02925"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K17836"],"award-info":[{"award-number":["19K17836"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24186"],"award-info":[{"award-number":["23K24186"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03518"],"award-info":[{"award-number":["19H03518"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15329"],"award-info":[{"award-number":["23K15329"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K15556"],"award-info":[{"award-number":["21K15556"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007591","name":"Akiyama Life Science Foundation","doi-asserted-by":"publisher","award":["2023"],"award-info":[{"award-number":["2023"]}],"id":[{"id":"10.13039\/100007591","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.canlet.2025.217941","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T16:47:14Z","timestamp":1753116434000},"page":"217941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["DOT1L inhibition reprograms innate immunity to potentiate immunomodulatory drug responses in multiple myeloma"],"prefix":"10.1016","volume":"631","author":[{"given":"Kazuya","family":"Ishiguro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7508-6764","authenticated-orcid":false,"given":"Hiroshi","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8634-663X","authenticated-orcid":false,"given":"Takeshi","family":"Niinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-5964","authenticated-orcid":false,"given":"Reo","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3678-4359","authenticated-orcid":false,"given":"Tomohide","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Hirohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Takaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-2874","authenticated-orcid":false,"given":"Kohei","family":"Kumegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Yoshido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yorozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Toyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Torigoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2848-6586","authenticated-orcid":false,"given":"Hiroshi","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9635-3238","authenticated-orcid":false,"given":"Hiromu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217941_bib1","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood.2020008733","article-title":"How I treat high-risk multiple myeloma","volume":"139","author":"Zamagni","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.217941_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ejh.13839","article-title":"The evolution of immune dysfunction in multiple myeloma","volume":"109","author":"Soekojo","year":"2022","journal-title":"Eur. J. Haematol."},{"issue":"Suppl 2","key":"10.1016\/j.canlet.2025.217941_bib3","first-page":"S4","article-title":"The immune system in multiple myeloma and precursor states: lessons and implications for immunotherapy and interception","volume":"98","author":"Dhodapkar","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.canlet.2025.217941_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00412-015-0570-5","article-title":"The upstreams and downstreams of H3K79 methylation by DOT1L","volume":"125","author":"Vlaming","year":"2016","journal-title":"Chromosoma"},{"key":"10.1016\/j.canlet.2025.217941_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3324\/haematol.2018.191262","article-title":"DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling","volume":"104","author":"Ishiguro","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2025.217941_bib6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.18632\/oncotarget.27493","article-title":"DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway","volume":"11","author":"Dafflon","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217941_bib7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s43018-023-00550-x","article-title":"Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias","volume":"4","author":"de Matos Simoes","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2025.217941_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41420-020-00400-0","article-title":"Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis","volume":"7","author":"Ishiguro","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2025.217941_bib9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217941_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"Dempster","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2025.217941_bib11","doi-asserted-by":"crossref","first-page":"D564","DOI":"10.1093\/nar\/gkac989","article-title":"EpiFactors 2022: expansion and enhancement of a curated database of human epigenetic factors and complexes","volume":"51","author":"Marakulina","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2025.217941_bib12","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.ccell.2023.11.001","article-title":"Therapeutic targeting of EP300\/CBP by bromodomain inhibition in hematologic malignancies","volume":"41","author":"Nicosia","year":"2023","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.canlet.2025.217941_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216472","article-title":"Dependency of B-Cell acute lymphoblastic leukemia and multiple myeloma cell lines on MEN1 extends beyond MEN1-KMT2A interaction","volume":"24","author":"Wolffhardt","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217941_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18446-z","article-title":"Identification of a CARM1 inhibitor with potent in vitro and in vivo activity in preclinical models of multiple myeloma","volume":"7","author":"Drew","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217941_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3892\/etm.2023.11973","article-title":"SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial-mesenchymal transition and PI3K\/AKT pathway activation","volume":"25","author":"Qian","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.canlet.2025.217941_bib16","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41589-020-0645-3","article-title":"ARID2 is a pomalidomide-dependent CRL4(CRBN) substrate in multiple myeloma cells","volume":"16","author":"Yamamoto","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2025.217941_bib17","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/leu.2017.144","article-title":"HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications","volume":"31","author":"Harada","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2025.217941_bib18","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1158\/1535-7163.MCT-20-0184","article-title":"Novel, selective inhibitors of USP7 uncover multiple mechanisms of antitumor activity in vitro and in vivo","volume":"19","author":"Ohol","year":"2020","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.217941_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13148-021-01160-z","article-title":"Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma","volume":"13","author":"Herviou","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.canlet.2025.217941_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-023-06036-z","article-title":"PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6","volume":"14","author":"Jia","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217941_bib21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/leu.2017.334","article-title":"Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma","volume":"32","author":"Gull\u00e0","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2025.217941_bib22","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/bjh.19796","article-title":"Combined MEK1\/2 and ATR inhibition promotes myeloma cell death through a STAT3-dependent mechanism in vitro and in vivo","volume":"205","author":"Li","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2025.217941_bib23","first-page":"4040","article-title":"Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma","volume":"109","author":"Puccio","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2025.217941_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.2007.06913.x","article-title":"The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma","volume":"140","author":"Evans","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2025.217941_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1158\/1541-7786.MCR-21-0366","article-title":"Chk1 inhibition potently blocks STAT3 Tyrosine705 phosphorylation, DNA-binding activity, and activation of downstream targets in human multiple myeloma cells","volume":"20","author":"Zhou","year":"2022","journal-title":"Mol. Cancer Res. : MCR"},{"key":"10.1016\/j.canlet.2025.217941_bib26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3324\/haematol.2023.282838","article-title":"TTK\/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma","volume":"109","author":"Longo","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2025.217941_bib27","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1535-7163.MCT-16-0141","article-title":"AZD5153: a novel bivalent BET bromodomain inhibitor highly active against hematologic malignancies","volume":"15","author":"Rhyasen","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.217941_bib28","doi-asserted-by":"crossref","first-page":"D852","DOI":"10.1093\/nar\/gkn732","article-title":"INTERFEROME: the database of interferon regulated genes","volume":"37","author":"Samarajiwa","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2025.217941_bib29","doi-asserted-by":"crossref","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","article-title":"Interferome v2.0: an updated database of annotated interferon-regulated genes","volume":"41","author":"Rusinova","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2025.217941_bib30","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/leu.2017.137","article-title":"MicroRNA-146a reduces MHC-II expression via targeting JAK\/STAT signaling in dendritic cells after stem cell transplantation","volume":"31","author":"Stickel","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2025.217941_bib31","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/emboj.2012.50","article-title":"Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1\/G2 cell-cycle phases","volume":"31","author":"Wakeman","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2025.217941_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41467-017-02687-7","article-title":"The protective role of DOT1L in UV-induced melanomagenesis","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217941_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13148-018-0601-1","article-title":"The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness","volume":"11","author":"Kari","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.canlet.2025.217941_bib34","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1016\/j.cell.2021.09.034","article-title":"Cytoplasmic DNA: sources, sensing, and role in aging and disease","volume":"184","author":"Miller","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217941_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.753789","article-title":"STING signaling and sterile inflammation","volume":"12","author":"Couillin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217941_bib36","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2018-05-850727","article-title":"IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of ikaros and aiolos","volume":"132","author":"Fedele","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.217941_bib37","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood.V94.12.4274","article-title":"Interferon consensus sequence binding protein and interferon regulatory factor-4\/Pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophages","volume":"94","author":"Rosenbauer","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.217941_bib38","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1073\/pnas.0508327102","article-title":"Negative regulation of toll-like-receptor signaling by IRF-4","volume":"102","author":"Negishi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.canlet.2025.217941_bib39","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1073\/pnas.0504226102","article-title":"Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS","volume":"102","author":"Honma","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217941_bib40","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/blood-2010-10-314278","article-title":"IMiD immunomodulatory compounds block C\/EBPbeta translation through eIF4E down-regulation resulting in inhibition of MM","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.217941_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2011.08689.x","article-title":"Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response","volume":"154","author":"Lopez-Girona","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2025.217941_bib42","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2017-12-818948","article-title":"The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia","volume":"131","author":"Stein","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.217941_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav5590","article-title":"Inhibition of histone methyltransferase DOT1L silences ER\u03b1 gene and blocks proliferation of antiestrogen-resistant breast cancer cells","volume":"5","author":"Nassa","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2025.217941_bib44","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1158\/1078-0432.CCR-21-1299","article-title":"DOT1L is a novel cancer stem cell target for triple-negative breast cancer","volume":"28","author":"Kurani","year":"2022","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.canlet.2025.217941_bib45","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1158\/0008-5472.CAN-16-1663","article-title":"The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription","volume":"77","author":"Wong","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217941_bib46","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1038\/s41467-020-18013-7","article-title":"Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer","volume":"11","author":"Vatapalli","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217941_bib47","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2643-3230.BCD-21-0047","article-title":"Bortezomib induces anti-multiple myeloma immune response mediated by cGAS\/STING pathway activation","volume":"2","author":"Gulla","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"5","key":"10.1016\/j.canlet.2025.217941_bib48","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10238-022-00878-1","article-title":"Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk\u2217MYC preclinical model","volume":"23","author":"Sokolowska","year":"2022","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.canlet.2025.217941_bib49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/bloodadvances.2017010413","article-title":"Zinc finger-IRF composite elements bound by Ikaros\/IRF4 complexes function as gene repression in plasma cell","volume":"2","author":"Ochiai","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2025.217941_bib50","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ccell.2022.09.007","article-title":"Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses","volume":"40","author":"Chan","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217941_bib51","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217941_bib52","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2141.1998.01000.x","article-title":"Human myeloma cell apoptosis induced by interferon-alpha","volume":"103","author":"Otsuki","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2025.217941_bib53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0301-472X(99)00156-3","article-title":"Interleukin-6 sensitizes multiple myeloma cell lines for apoptosis induced by interferon-alpha","volume":"28","author":"Minami","year":"2000","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.canlet.2025.217941_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2141.2003.04255.x","article-title":"Anti-tumour activity of interferon-alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiation","volume":"121","author":"Matsui","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2025.217941_bib55","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1038\/sj.onc.1206503","article-title":"Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax","volume":"22","author":"Panaretakis","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217941_bib56","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1182\/blood.2020006113","article-title":"Novel inhibitors of the histone methyltransferase DOT1L show potent antileukemic activity in patient-derived xenografts","volume":"136","author":"Perner","year":"2020","journal-title":"Blood"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525005105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525005105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:21:43Z","timestamp":1769743303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525005105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":56,"alternative-id":["S0304383525005105"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217941","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DOT1L inhibition reprograms innate immunity to potentiate immunomodulatory drug responses in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217941"}}